Preventive Healthcare Market

Global Preventive Healthcare Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Rising geriatric population along with chronic diseases, increasing healthcare awareness among people, and growing R&D activities to develop innovative techniques drive the growth of Market.

Global Preventive Healthcare Market is valued at USD 3468.1 Million in 2021 and expected to reach USD 6103.5 Million by 2028 with a CAGR of 8.41% over the forecast period.

Scope-

Preventive healthcare, or prophylaxis, comprises of measures taken for the motivations behind disease prevention. Preventive healthcare manages the prevention of illness to diminish the burden of illness and related risk factors. Preventive measures can be applied at all stages across the life expectancy and along a disease range, to avoid further downfall after some time. There are different degrees of prevention, gives instances of preventive suggestions, and examines a portion of the discussion inside the disciplines of the populace and public health. Preventive healthcare is particularly significant given the overall rise in the prevalence of chronic diseases and deaths from these sicknesses. There are numerous techniques for the prevention of illness. One of them is the prevention of young smoking through data giving. It is prescribed that grown-ups and youngsters plan to visit their doctor for regular check-ups, regardless of whether they feel healthy, to perform sickness screening, distinguish risk factors for infection, examine tips for a healthy and balanced lifestyle, stay up to date with boosters and immunizations, and keep a decent connection with a healthcare supplier.

The Covid-19 pandemic has also impacted the growth of the global field service management market. During the Covid-19 pandemic, preventive healthcare has expanded in significance across the world. With Coronavirus pandemic making individuals more aware of disease prevention and immunity boosting. During the Covid-19 pandemic, government of different countries applied preventive measures such as physical or social separation, isolating, ventilation of indoor spaces, covering sneezes and coughs, hand washing, and getting unwashed hands far from the face. The utilization of face masks or covers has been prescribed in public settings to limit the risk of Covid-19 transmissions.

The global preventive healthcare market is segmented on the basis of type, model type, application, and region & country level. Based upon the type, the market is classified into advanced technologies to reduce errors, early detection & screening technologies, chronic disease management technologies, and vaccines. Based upon the model type, the market is classified into hybrid management model, in-house management mode, and outsourced management. Based on application, the preventive healthcare market is classified into hospitals and clinics.

The regions covered in global preventive healthcare market report are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global preventive healthcare is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (Saudi Arabia, UAE, Egypt) GCC, Africa, etc.

Key Players-

Some major key players for global preventive healthcare market report cover prominent players like -

• McKesson Corporation
• Abbott Laboratories
• Healthways Inc.
• Medtronic PLC
• Merck & Co. Inc.
• Biocon Limited
• Dilon Technologies Inc.
• Omnicell Inc.
• Alere Inc.
• GlaxoSmithKline PLC
• Pfizer Inc.
• Quest Diagnostics Inc.
• others

Segmentation-

By Type:

• Advanced Technologies to Reduce Errors
• Early Detection & Screening Technologies
• Chronic Disease Management Technologies
• Vaccines

By Model Type:

• Hybrid Management Model
• In-House Management Mode
• Outsourced Management

By Organization Size:

• Hospitals
• Clinics

By Regional & Country Level:

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • France
  • Germany
  • Italy

• Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

• Latin America

  • Brazil
  • Mexico

• Middle East and Africa

  • GCC
  • Africa
  • Rest of Middle East and Africa

Rising Geriatric Population Coupled with Chronic Diseases, Increasing Healthcare Awareness among People, and Growing R&D of Innovative Technique Drive the Market Growth

One of the major factors driving the growth of the global preventive healthcare market is the growing geriatric population coupled with chronic diseases. An expansion in the geriatric population pool is expanding interest for the preventive healthcare advancements and services market. Medical issues are known to increment with age, because of this identifying or preventing issues at the beginning phase can reduce the risk and intensity of the issue. This rise in the geriatric population can likewise straightforwardly affect the preventive healthcare technologies market. For example; as per the World Health Organization (WHO), the quantity of individuals matured 60 years and more established was 1 billion in 2019. This number will increment to 1.4 billion by 2030 & 2.1 billion by 2050.

In addition, increasing healthcare awareness among people is also supplementing the market growth. Developing awareness with regard to preventable techniques is supposed to assume a significant role in improving the quality of life. Preventive healthcare is tied in with spending less and remaining fit rather than spending a fortune on therapies upon illness diagnosis. For instance; on September 7^th, 2022; Walmart and medical care giant UnitedHealth Group are planning to collaborate to give preventive care to individuals aged 65 and up, and essential healthcare services for all age groups. Walmart's work with UnitedHealth will target normal ailments among aging Americans like diabetes and heart disease.

Furthermore, growing R&D activities to develop more innovative techniques and continuously changing weather conditions remaining to change patterns of illness also drive the global preventive healthcare market. However, the high costs associated with preventive healthcare may hamper the global preventive healthcare market growth. In spite of that, the rising development of healthcare infrastructure in developing countries can provide various opportunities for the further growth of the market.

North America is Anticipated to Dominate the Global Preventive Healthcare Market

North America is expected to dominate the global preventive healthcare market within the forecast period due to the increasing prevalence of chronic diseases, growing geriatric population, and presence of key players in this region. For example; according to the Centers for Disease Control and Prevention (CDC), in 2020, there are about 697,000 people died from heart disease in the United States. Moreover, the increasing geriatric population also drives the preventive healthcare market in this region. For instance; according to the U.S. Census Bureau, more than 54 million adults ages 65 and older live in the United States are accounting for approximately 16.5% of the nation's population. The overall number of grown-ups ages 65 and more seasoned is projected to increase to an expected 85.7 million by 2050 generally 22% of the total U.S. populace.

The Asia Pacific is anticipated to grow faster in the global preventive healthcare market due to the rising prevalence of diabetes and advancement in technology in this region. Rising cases of diabetic patients increase the demand for the preventive healthcare market over the forecast period. For instance; according to the National Center for Biotechnology Information (NCBI), in 2019 there are about 77 million people had diabetes in India, which is anticipated to increase to more than 134 million by 2045. Also, advancement in technology drives the market in the Asia Pacific region. For example, on March 29^th, 2022, Mumbai-based GOQii, the smart preventive healthcare organization which has forever been at the forefront of development, has extended its preventive medical care portfolio with stylish offerings. GOQii's contributions incorporate a fitness tracker, coaching, health store, app, protection, and numerous others. GOQii has been a pioneer in getting developing innovations in preventive healthcare.

News-

Users More Likely to Embrace AI-Enabled Preventive Health Measures with Human Touch, Study Finds

On September 7^th, 2022; A study led by researchers from the Nanyang Technological University Singapore has revealed that individuals are more likely to accept preventive health interventions suggested by AI with the involvement of human health experts. It also found lesser trust in AI-powered preventive care than in interventions led by human experts.

Report Analysis	Details
Historical data	2018 - 2021
Forecast Period	2022 - 2028
Market Size in 2021:	USD 3468.1 Million
Base year considered	2021
Forecast Period CAGR %:	8.41%
Market Size Expected in 2028:	USD 6103.5 Million
Tables, Charts & Figures:	175
Pages	200
Companies	McKesson Corporation, Abbott Laboratories, Healthways, Inc., Medtronic PLC, Merck & Co., Inc., Biocon Limited, Dilon Technologies, Inc., Omnicell, Inc., Alere Inc.,  GlaxoSmithKline PLC, Pfizer, Inc., Quest Diagnostics, Inc. and others.
Segments Covered	By Type, By Model Type, By Organization Size
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa